The Seattle Cancer Care Alliance (SCCA) director of public relations is available to assist journalists with questions regarding SCCA, its partner organizations and its patients.

Our goal is to facilitate and encourage open and positive relationships between SCCA staff and the media while ensuring that all communications result in an accurate and appropriate portrayal of SCCA activities.

The public relations staff is committed to guarding the privacy and confidentiality of all patients undergoing treatment while recognizing the rights of the individual patient to discuss any and all aspects of his or her treatment and health status with the general public through the media. Patients must sign consent forms before any information will be given out.

Contact us

Journalists are welcome to visit SCCA. An escort will be available during visits. To arrange an interview, videotaping session or photo shoot, please contact:

Karina San Juan Guyton
SCCA Director of Communications & Public Relations
Media Coverage
Displaying 10 most recent
COVID-19 Vaccines Are Entering Uncharted Immune Territory
The Atlantic · Published April 15, 2021
Dr. Coveler on the Toxicity Profile of NUC-3373 in Metastatic CRC
OncLive · Published April 13, 2021
Dr. Till on Data With Liso-Cel Vs Other Products Under Examination in MCL
OncLive · Published April 13, 2021
Avelumab first-line maintenance in locally advanced or metastatic urothelial carcinoma: Applying clinical trial findings to clinical practice
UroToday · Published April 13, 2021
Here’s Where Some People First Looked for Information After Their Cancer Diagnosis
CURE · Published April 12, 2021
Sanofi’s, AstraZeneca’s and Radius’ oral SERDs could establish clinical worth in ER+ breast cancer by showing similar efficacy to Faslodex, experts say
Clinical Trials Arena · Published March 19, 2021
Evolving Landscape for Frontline Treatment in Clear Cell Metastatic Renal Cell Carcinoma
UroToday · Published March 18, 2021
New COVID-19 Treatment Advice and Vaccine Guidance for Cancer Patients
National Comprehensive Cancer Network · Published March 18, 2021
Helping spread kidney cancer awareness
Binaytara Foundation · Published March 17, 2021
‘On-your-toes’ approach to managing infection risk needed as CAR T-cell therapy evolves
Healio · Published March 17, 2021
Press Releases
Displaying 10 most recent
Clinical Oncology Findings from Seattle Cancer Care Alliance (SCCA) Clinicians to be Featured at the 2021 ASCO Annual Meeting
SCCA Staff · Published June 3, 2021
More than 40 Seattle Cancer Care Alliance Physicians Receive Seattle Magazine “Top Doctors” Recognition
SCCA Staff · Published May 17, 2021
Seattle Cancer Care Alliance is an Authorized Treatment Center for Ide-cel CAR T-Cell Therapy
SCCA Staff · Published May 13, 2021
Seattle Cancer Care Alliance Awards Community Health Grants to Regional Nonprofits
SCCA Staff · Published April 13, 2021
Seattle Cancer Care Alliance Selected as an Authorized Treatment Center for BreyanziTM/Liso-Cel CAR T-Cell Treatment
SCCA Staff · Published February 18, 2021
Seattle Cancer Care Alliance Celebrates 20 Years of Innovation in Cancer Treatment and Care
SCCA Staff · Published February 10, 2021
Seattle Cancer Care Alliance Among First Washington Healthcare Providers to Receive COVID-19 Vaccine
SCCA staff · Published December 15, 2020
SCCA to Present New Research at 62nd Annual Meeting of the ASH
Published December 4, 2020
Seattle Cancer Care Alliance Selected as an Authorized Treatment Center for Tecartus™, a Novel Immunotherapy Treatment
Published October 8, 2020
Seattle Cancer Care Alliance Nursing Staff Leads 10 Poster Presentations at Oncology Nursing Society Bridge Virtual Conference
Published September 8, 2020